C.A. Uyl-de Groot
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Neutropenia and Cancer Infections
Papers in
-
- Economic and Financial Impacts of Cancer 6
- Health Systems, Economic Evaluations, Quality of Life 6
- Oncology 7
- Neutropenia and Cancer Infections 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Frans Rutten (4 shared papers)Peter C. Huijgens (6 shared papers)Gouke J. Bonsel (2 shared papers)LF Verdonck (2 shared papers)Bob Löwenberg (2 shared papers)Pieter Sonneveld (3 shared papers)Michel van Agthoven (3 shared papers)Anton Hagenbeek (1 shared paper)
- Journals
- Value in Health (7 papers)European Journal of Cancer (5 papers)European Archives of Oto-Rhino-Laryngology (2 papers)Journal of Clinical Oncology (2 papers)BMC Psychiatry (1 paper)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
C.A. Uyl-de Groot
27 papers receiving 529 citations
Peers
Comparison fields: 5 of 72
- Hematology 118
- Oncology 258
- Genetics 71
- Clinical Biochemistry 45
- Pathology and Forensic Medicine 116
Countries citing papers authored by C.A. Uyl-de Groot
This map shows the geographic impact of C.A. Uyl-de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.A. Uyl-de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.A. Uyl-de Groot more than expected).
Fields of papers citing papers by C.A. Uyl-de Groot
This network shows the impact of papers produced by C.A. Uyl-de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.A. Uyl-de Groot. The network helps show where C.A. Uyl-de Groot may publish in the future.
Co-authors
The 25 scholars most cited alongside C.A. Uyl-de Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 132 | |
| 2 | 1996 | 69 | |
| 3 | Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL). | 1995 | 53 |
| 4 | 2012 | 46 | |
| 5 | 2012 | 41 | |
| 6 | 1994 | 32 | |
| 7 | 1994 | 30 | |
| 8 | 1993 | 28 | |
| 9 | 1996 | 17 | |
| 10 | Cost analysis of regular and filgrastim treatment in patients with refractory chronic rhinosinusitis. | 2002 | 17 |
| 11 | 2007 | 12 | |
| 12 | 2021 | 12 | |
| 13 | 2014 | 10 | |
| 14 | 2016 | 9 | |
| 15 | 2017 | 8 | |
| 16 | 2013 | 8 | |
| 17 | 2013 | 7 | |
| 18 | 1999 | 4 | |
| 19 | Access to expensive cancer drugs in Dutch daily practice: should we be concerned? | 2014 | 4 |
| 20 | 2017 | 3 |
About C.A. Uyl-de Groot
C.A. Uyl-de Groot is a scholar working on Economics and Econometrics, Oncology, Pulmonary and Respiratory Medicine, Hematology and Public Health, Environmental and Occupational Health, having authored 28 papers that have together received 553 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Lung Cancer Treatments and Mutations (3 papers), Neutropenia and Cancer Infections (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Hematology (118 citations), Oncology (258 citations), Genetics (71 citations), Clinical Biochemistry (45 citations) and Pathology and Forensic Medicine (116 citations). C.A. Uyl-de Groot has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Frans Rutten, Peter C. Huijgens, Gouke J. Bonsel, LF Verdonck, Bob Löwenberg, Pieter Sonneveld, Michel van Agthoven, Anton Hagenbeek, Edo Vellenga and Dick J. Richel. Their work appears in journals such as Value in Health, European Journal of Cancer, European Archives of Oto-Rhino-Laryngology, Journal of Clinical Oncology and BMC Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.